OpenAI has acquired Torch, a startup focused on creating a unified medical memory for AI, for about $60 million. The deal aims to centralize patient health data, which is often fragmented across various systems. Torch's CEO, Ilya Abyzov, expressed excitement about integrating their technology with OpenAI's existing health tools.

OpenAI introduced ChatGPT Health, allowing users to link their medical records and wellness apps to the chatbot. This feature aims to provide tailored responses based on individual health information, though it’s not for diagnosis or treatment. Initial access will be limited to a small group of users for feedback.

OpenAI is actively expanding its influence in the healthcare sector by developing artificial intelligence technologies aimed at enhancing medical research and patient management. The company is collaborating with industry leaders to leverage machine learning for improving diagnostics and treatment options, indicating a significant shift towards integrating AI in healthcare practices.

The FDA is exploring the use of AI, specifically through discussions with OpenAI, to expedite the drug approval process. This initiative, led by the FDA's first AI officer, aims to modernize regulatory reviews, although concerns about AI reliability and proper data training persist.